Quant Healthcare Fund - Growth - Direct Plan

Other Plans and Options
  • 0.82 %Nav, as on 15-07-2025

  • Previous Nav

  • Net Change on 15-07-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty India Consumption - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 13.61 25.37 23.00 0.89 8,569.15
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option Jul 13, 2018 19.57 29.78 25.61 1.05 5,727.59
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 20.12 29.51 25.34 0.89 3,849.24
Mirae Asset Healthcare Fund Direct Growth Jul 02, 2018 16.18 24.99 24.25 0.49 2,785.12
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Dec 28, 2015 13.18 25.49 23.77 0.62 1,281.99

Fund Holdings as on 30-June-2025

  • Divi's Laboratories Limited

  • Aster DM Healthcare Limited

  • TREPS 01-Jul-2025 DEPO 10

  • RPG Life Sciences Limited

  • Sequent Scientific Limited

  • Pfizer Ltd

  • Zydus Wellness Ltd

  • Lupin Limited 31/07/2025

  • HDFC Life Insurance Co Ltd

  • Alivus Life Sciences

  • Aurobindo Pharma Limited

  • SMS Pharmaceuticals Limited

  • HFCL Limited

  • Sun Pharmaceutical Industries Limited

  • Laxmi Dental Limited

  • Sun Pharmaceutical Industries Limited 31/07/2025

  • Lupin Limited

  • Aurobindo Pharma Limited 31/07/2025

  • Suraksha Diagnostic Limited

  • 91 Days Treasury Bill 17-Jul-2025

  • 91 Days Treasury Bill 21-Aug-2025

  • 91 Days Treasury Bill 18-Sep-2025

  • 91 Days Treasury Bill 28-Aug-2025

  • 91 Days Treasury Bill 25-Sep-2025

  • 91 Days Treasury Bill 11-Sep-2025

  • 182 Days Treasury Bill 04-Sep-2025

  • 91 Days Treasury Bill 04-Sep-2025

  • NCA-NET CURRENT ASSETS

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Consumer Food

  • Insurance

  • Telecom-Infrastructure

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Derivatives

  • Equity

  • Sov

View More

About Quant Healthcare Fund

Scheme Analysis

Quant Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Quant Mutual Fund. It was launched on 17-Jul-2023 and currently has an AUM of ₹425.34 crore. Quant Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty India Consumption - TRI as secondary index.

The NAV of Quant Healthcare Fund ended up ₹0.13(0.82%)yesterday to ₹16.2496.

Among its top 3 holdings the fund has exposure to Divi's Laboratories Limited, and

The Quant Healthcare Fund is managed by Ankit Pande and Sandeep Tandon.

Fund House Contact

6th Floor, Sea Breeze Building, Appa Saheb Marathe Marg, Prabhadevi, Mumbai - 400025

022-6295 5000
help@quant.in
022-6295 5000